The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BeiGene, Ltd(NASDAQ:BGNE) 
BeiGene, Ltd., a commercial-stage biotechnology company, engages in discovering, developing, manufacturing, and commercializing medicines for cancer therapeutics in the People's Republic of China and the United States. Its commercial products include BRUKINSA to treat relapsed/refractory (R/R) mantl...
Website: http://www.beigene.com
Founded: 2010
Full Time Employees: 9,400 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
BeiGene Number of Employees (headcount)
BeiGene Days Payable Outstanding ttm (DPO)
BeiGene Days Receivable Outstanding ttm (DSO)
BeiGene Days Inventory Outstanding ttm (DIO)
BeiGene Op Cashflow Per Share ttm
BeiGene Free Cashflow Per Share ttm
BeiGene Cash Per Share ttm
BeiGene P/S ratio ttm
BeiGene (GAAP) P/E ratio ttm
BeiGene P/B ratio ttm
No extra charts and metrics for this ticker.